Fundamentals data is not available for this company.
No recent information was found.
| Dynavax, Merck team up on hepatitis B vaccine | 02-Nov-2007 | BayArea.com |
| Merck Buys License to Sell New Vaccine for Hepat... | 01-Nov-2007 | New York Times |
| Business Digest | 20-Jan-2006 | BayArea.com |
| Currency | US Dollars |
| Share Price | $ 15.62 |
| Change Today | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $15.72 |
| 52 Week Low | $9.36 |
| Volume | 275 |
| Shares Issued | 65.06m |
| Market Cap | $1,016.30m |
| RiskGrade | 699 |
You are here: research